Literature DB >> 17363894

Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Felipe Andrade1, Edward Fellows, Dieter E Jenne, Antony Rosen, C S H Young.   

Abstract

Granzymes are key components of the immune response that play important roles in eliminating host cells infected by intracellular pathogens. Several granzymes are potent inducers of cell death. However, whether granzymes use additional mechanisms to exert their antipathogen activity remains elusive. Here, we show that in adenovirus-infected cells in which granzyme B (gzmB) and downstream apoptosis pathways are inhibited, granzyme H (gzmH), an orphan granzyme without known function, directly cleaves the adenovirus DNA-binding protein (DBP), a viral component absolutely required for viral DNA replication. We directly addressed the functional consequences of the cleavage of the DBP by gzmH through the generation of a virus that encodes a gzmH-resistant DBP. This virus demonstrated that gzmH directly induces an important decay in viral DNA replication. Interestingly, gzmH also cleaves the adenovirus 100K assembly protein, a major inhibitor of gzmB, and relieves gzmB inhibition. These results provide the first evidence that granzymes can mediate antiviral activity through direct cleavage of viral substrates, and further suggest that different granzymes have synergistic functions to outflank viral defenses that block host antiviral activities.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363894      PMCID: PMC1852776          DOI: 10.1038/sj.emboj.7601650

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  58 in total

Review 1.  Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

Authors:  Justin Bailey; Joel N Blankson; Megan Wind-Rotolo; Robert F Siliciano
Journal:  Curr Opin Immunol       Date:  2004-08       Impact factor: 7.486

2.  Studies on adenovirus type 9-induced mammary fibroadenomas in rats and their malignant transformation.

Authors:  N Jonsson; J Ankerst
Journal:  Cancer       Date:  1977-06       Impact factor: 6.860

3.  Characterization of adenovirus type 5 insertion and deletion mutants encoding altered DNA binding proteins.

Authors:  H L Vos; D E Brough; F M Van der Lee; R C Hoeben; G F Verheijden; D Dooijes; D F Klessig; J S Sussenbach
Journal:  Virology       Date:  1989-10       Impact factor: 3.616

4.  Tumour production in immunosuppressed rats with cells transformed in vitro by adenovirus type 2.

Authors:  P H Gallimore
Journal:  J Gen Virol       Date:  1972-07       Impact factor: 3.891

5.  Analysis of expression of adenovirus DNA (fragments) by microinjection in Xenopus oocytes. Independent synthesis of minor early region 2 proteins.

Authors:  F A Asselbergs; J E Smart; M B Mathews
Journal:  J Mol Biol       Date:  1983-01-15       Impact factor: 5.469

6.  Isolation and analysis of adenovirus type 5 mutants containing deletions in the gene encoding the DNA-binding protein.

Authors:  S A Rice; D F Klessig
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

7.  Host range temperature-conditional mutants in the adenovirus DNA binding protein are defective in the assembly of infectious virus.

Authors:  J C Nicolas; P Sarnow; M Girard; A J Levine
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

8.  The stability of early adenovirus mRNA is controlled by the viral 72 kd DNA-binding protein.

Authors:  A Babich; J R Nevins
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

9.  Lymphokine-activated killer cells. Analysis of progenitors and effectors.

Authors:  J R Ortaldo; A Mason; R Overton
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

10.  Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis.

Authors:  J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1986-09-01       Impact factor: 14.307

View more
  35 in total

Review 1.  A quarter century of granzymes.

Authors:  C L Ewen; K P Kane; R C Bleackley
Journal:  Cell Death Differ       Date:  2011-11-04       Impact factor: 15.828

Review 2.  Death by a thousand cuts: granzyme pathways of programmed cell death.

Authors:  Dipanjan Chowdhury; Judy Lieberman
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Viral subversion of apoptotic enzymes: escape from death row.

Authors:  Sonja M Best
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

4.  Structure of granzyme C reveals an unusual mechanism of protease autoinhibition.

Authors:  Dion Kaiserman; Ashley M Buckle; Petra Van Damme; James A Irving; Ruby H P Law; Antony Y Matthews; Tanya Bashtannyk-Puhalovich; Chris Langendorf; Philip Thompson; Joël Vandekerckhove; Kris Gevaert; James C Whisstock; Phillip I Bird
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-19       Impact factor: 11.205

Review 5.  Endolysosomal proteases and their inhibitors in immunity.

Authors:  Phillip I Bird; Joseph A Trapani; José A Villadangos
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

Review 6.  Perforin and granzymes: function, dysfunction and human pathology.

Authors:  Ilia Voskoboinik; James C Whisstock; Joseph A Trapani
Journal:  Nat Rev Immunol       Date:  2015-06       Impact factor: 53.106

7.  Autoreactive T effector memory differentiation mirrors β cell function in type 1 diabetes.

Authors:  Lorraine Yeo; Alyssa Woodwyk; Sanjana Sood; Anna Lorenc; Martin Eichmann; Irma Pujol-Autonell; Rosella Melchiotti; Ania Skowera; Efthymios Fidanis; Garry M Dolton; Katie Tungatt; Andrew K Sewell; Susanne Heck; Alka Saxena; Craig A Beam; Mark Peakman
Journal:  J Clin Invest       Date:  2018-07-16       Impact factor: 14.808

8.  Granzyme K-deficient mice show no evidence of impaired antiviral immunity.

Authors:  Lars T Joeckel; Cody C Allison; Marc Pellegrini; Catherina H Bird; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-04-21       Impact factor: 5.126

9.  A pro-survival role for the intracellular granzyme B inhibitor Serpinb9 in natural killer cells during poxvirus infection.

Authors:  Matthew S Mangan; Carolina R Melo-Silva; Jennii Luu; Catherina H Bird; Aulikki Koskinen; Alexandra Rizzitelli; Monica Prakash; Katrina L Scarff; Arno Müllbacher; Matthias Regner; Phillip I Bird
Journal:  Immunol Cell Biol       Date:  2017-08-15       Impact factor: 5.126

10.  Human cytomegalovirus elicits fetal gammadelta T cell responses in utero.

Authors:  David Vermijlen; Margreet Brouwer; Catherine Donner; Corinne Liesnard; Marie Tackoen; Michel Van Rysselberge; Nicolas Twité; Michel Goldman; Arnaud Marchant; Fabienne Willems
Journal:  J Exp Med       Date:  2010-04-05       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.